Dr. Jennifer Anne Whitaker, MD

Dr. Whitaker practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Whitaker's NPI, 1316124746, was assigned on January 29, 2008. Dr. Whitaker graduated from Indiana University School Of Medicine in 2006. Dr. Whitaker holds Texas license S0404.

Dr. Whitaker's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Whitaker's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. Dr. Whitaker is also affiliated with Harris Health Ben Taub Hospital. The medical group on file is Baylor College of Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Whitaker practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Whitaker's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Whitaker is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Whitaker's licenses on file in 3 states: Texas, Minnesota and Georgia.

Dmand AI lists hiv/aids among the conditions Dr. Whitaker treats.

CMS data shows 158 Medicare services from Dr. Whitaker across 4 procedure codes in 2018, for 12 Medicare patients. Medicare paid $13,524 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 12 Medicare patients who saw Dr. Whitaker in 2024. The largest group is 75 to 84, with 0 patients. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Whitaker's median patient age at 58, with 52% women.

In 2024, Dr. Whitaker wrote 748 Medicare Part D claims for 30 patients. 61% of them were for generic drugs. CMS names the drug for 568 of them, across 24 drugs with 11 or more claims each, at $743,101 in total drug cost. In 2023, CMS named 573 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Whitaker for performance year 2024, reported as part of a group. Dr. Whitaker accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 55 papers to Dr. Whitaker, published from 2011 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Vaccination, Antibodies, Viral and COVID-19. Dr. Whitaker has published most often in Vaccine. Dr. Whitaker's most frequent co-authors are Robert L. Atmar, MD, Patricia Lee Winokur, MD and Lindsey Robert Baden, MD.

Dmand AI links Dr. Whitaker to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Latent Infection and Latent Tuberculosis.

CMS Open Payments shows 10 general payments to Dr. Whitaker from 2 drug and device companies from 2016 to 2017. Speaker and faculty fees make up the largest share, 99% of the total. Pfizer Inc. paid the most, $19,757.

Dr. Whitaker graduated from Indiana University School Of Medicine in 2006. Dr. Whitaker is a member of ACP and IDSA.

Dr. Whitaker is in network with 16 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.